G1 Therapeutics
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -5.11 | -100% |
| P/S |
|
1.87 | 33.76 | -94.47% |
|
|
| P/BV |
|
4.36 | 4.82 | -9.63% |
|
|
| P/FCF |
|
-2.46 | 60.98 | -104.03% |
|
|
| Ev/Ebitda |
|
-4.59 | -22.12 | -79.25% |
|
|
| Ev/S |
|
2.17 | 22.56 | -90.38% |
|
|
| Ev/FCF |
|
-4.67 | 68.75 | -106.79% |
|
|
| E/P |
|
-0.5092 | 0.0178 | -2964.91% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-47.28 | 4.83 | -1078.88% | -1401.18 | -96.63% |
| ROE |
|
-135.55 | 9.61 | -1511.11% |
|
|
| ROA |
|
-39.47 | 0.3359 | -11849.14% |
|
|
| ROIC |
|
-71.97 | 7.63 | -1042.71% |
|
|
| ROS |
|
-58.13 | -25.17 | 130.95% |
|
|
| ROCE |
|
-111.7 | 15.33 | -828.6% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-1.35 | -3.67 | -63.06% | -0.8409 | 61.05% |
| Nеt Debt/Ebitda |
|
-0.638 | -3.44 | -81.45% |
|
|
| Debt/Ratio |
|
0.4347 | 0.1972 | 120.49% |
|
|
| Debt/Equity |
|
26.42 | 1.65 | 1504.46% |
|
|
| Debt/Net Income |
|
-1.1 | 10.31 | -110.69% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5496 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.1053 | -100% |
|
|
| DSI |
|
0 | 0.2174 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0654 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5496 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
10/10
|
3829.1 | -56.89 | -6830.71% |
| Growth impulse Ebitda 5 years |
|
-69.76 | -64.81 | 7.64% |
| Growth impulse Net Income 5 years |
|
-58.47 | -58.33 | 0.24% |
| Growth impulse FCF 5 years |
|
-62.52 | -47 | 33.02% |
| Growth impulse EPS 5 years |
|
-69.9 | -32.41 | 115.67% |
IP Score
3.05/10
